A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
NCT00036374 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 123
Last updated 2011-05-17
Summary
The purpose of this study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with Juvenile Rheumatoid Arthritis (JRA).
Conditions
- Rheumatoid Arthritis, Juvenile
Interventions
- DRUG
Sponsors & Collaborators
-
Centocor, Inc.
lead INDUSTRY
Principal Investigators
-
Centocor, Inc. Clinical Trial · Centocor, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-10-31
- Completion
- 2006-12-31
More Related Trials
-
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
NCT00760669 ·Status: COMPLETED
-
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
NCT02277444 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
NCT00317538 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
NCT00051623 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
NCT00896168 ·Status: COMPLETED ·Phase: PHASE4
-
The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
NCT04779892 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
NCT00299546 ·Status: COMPLETED ·Phase: PHASE3
-
Intraarticular Injection of Infliximab
NCT00521963 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
NCT00207701 ·Status: COMPLETED ·Phase: PHASE3
-
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy
NCT00973479 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00361335 ·Status: COMPLETED ·Phase: PHASE3
-
The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol
NCT00246064 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
NCT00264537 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab for the Treatment of Early Rheumatoid Arthritis
NCT00006292 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
NCT00724243 ·Status: COMPLETED
-
A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
NCT01962974 ·Status: TERMINATED ·Phase: PHASE3
-
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
NCT00207714 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00264550 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis
NCT01567358 ·Status: COMPLETED ·Phase: PHASE1
-
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
NCT03885037 ·Status: COMPLETED
-
INCB047986 in Rheumatoid Arthritis
NCT02151474 ·Status: TERMINATED ·Phase: PHASE2
-
A Study in Patients With Rheumatoid Arthritis
NCT00966875 ·Status: COMPLETED ·Phase: PHASE2
-
Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)
NCT00394589 ·Status: TERMINATED ·Phase: PHASE3
-
Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
NCT00883896 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)
NCT00794898 ·Status: COMPLETED ·Phase: PHASE4